Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Edward A. Stadtmauer, MD

Edward A. Stadtmauer, MD Physician

Section Chief, Hematologic Malignancies Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Dr. Stadtmauer is employed by Penn Medicine.

About Dr. Edward A. Stadtmauer

Recognized by America's Top Doctors, 2007, 2008, 2010, 2011 - 2018

Recognized by Best Doctors in America 2003 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues from 2005 - 2008, 2011, and 2013 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Hematology

Programs & Centers:

Board Certification:

  • Hematology, 1988
  • Internal Medicine, 1986
  • Medical Oncology, 1989

Clinical Expertise:

  • Acute Lymphocytic Leukemia
  • Acute Myelogenous Leukemia
  • Acute Promyelocytic Leukemia
  • Adult T-Cell Leukemia
  • Adult T-Cell Lymphoma
  • AIDS Related Malignancies
  • Amyloidosis
  • Anaplastic Large Cell Lymphoma
  • Bone Marrow Biopsy
  • Bone Marrow Failure Syndromes
  • Burkitt Lymphoma
  • Cancer During Pregnancy
  • Castleman Disease
  • Chronic Lymphocytic Leukemia
  • Chronic Myelocytic Leukemia
  • Chronic Myelomonocytic Leukemia
  • CNS Lymphoma
  • Cutaneous Lymphoma
  • Eosinophilic Granuloma
  • Erdheim-Chester Disease
  • Essential Thrombocytosis
  • Graft Versus Host Disease
  • Hairy Cell Leukemia
  • Hematologic Malignancies
  • Histiocytosis
  • HIV Lymphoma
  • HIV Malignancies
  • Hodgkin Lymphoma
  • Intraocular Lymphoma
  • Large Granular Lymphocytic Leukemia
  • Leukemia
  • Light Chain Disorders
  • Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Lymphoma
  • Monoclonal Gammopathy of Undetermined Significance
  • Mucosa-Associated Lymphoid Tissue Lymphoma
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Non-Hodgkin Lymphoma
  • Pelvic Malignancy During Pregnancy
  • Peripheral T-Cell Lymphoma
  • Plasma Cell Dyscrasia
  • POEMS Syndrome
  • Polycythemia
  • Primary Myelofibrosis
  • Prolymphocytic Leukemia
  • Refractory Anemia With Excess Blasts
  • Sezary Syndrome
  • Transformed Lymphoma
  • Waldenstrom Macroglobulinemia (WM)
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Bronx Municipal Hospital - Albert Einstein College
Fellowship: Hospital of the University of Pennsylvania


American College of Physicians, Fellow, National American Federation for Clinical Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Autologous Bone Marrow Transplant Registry (ABMTR/CIBMTR), National Bone Marrow Transplant Clinical Trials Network, National Eastern Cooperative Oncology Group, National Foundation for the Accreditation of Hematopoietic Cell Therapy, National International Myeloma Working Group, International Membership in External Advisory Committees, Endpoint Review Committees, and Data Safety and Monitoring Boards, International Membership in National Scientific Review Panels, National NCI Myeloma Steering Committee, National NIAID Hematopoietic Stem Cell Transplantation Data Safety Monitoring Board (HSCT DSMB), National

Hospital Affiliation

Dr. Stadtmauer is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Clinical trials, Bone Marrow Transplant

Selected Publications:

Garfall AL, Dancy EK, Cohen AD, Hwang WT, Fraietta JA, Davis MM, Levine BL, Siegel DL, Stadtmauer EA, Vogl DT, Waxman A, Rapoport AP, Milone MC, June CH, Melenhorst JJ: T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma. Blood Advances : 2019.

Cornell Robert F, Ky Bonnie, Weiss Brendan M, Dahm Cherie N, Gupta Deepak K, Du Liping, Carver Joseph R, Cohen Adam D, Engelhardt Brian G, Garfall Alfred L, Goodman Stacey A, Harrell Shelton Lacy, Kassim Adetola A, Jadhav Trafina, Jagasia Madan, Moslehi Javid, O'Quinn Rupal, Savona Michael R, Slosky David, Smith Amanda, Stadtmauer Edward A, Vogl Dan T, Waxman Adam, Lenihan Daniel: Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 37 (22): 1946-1955,2019.

Stadtmauer Edward A, Faitg Thomas H, Lowther Daniel E, Badros Ashraf Z, Chagin Karen, Dengel Karen, Iyengar Malini, Melchiori Luca, Navenot Jean-Marc, Norry Elliot, Trivedi Trupti, Wang Ruoxi, Binder Gwendolyn K, Amado Rafael, Rapoport Aaron P: Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma. Blood advances 3 (13): 2022-2034,2019.

Ziegler Matthew, Landsburg Daniel, Pegues David, Bilker Warren, Gilmar Cheryl, Kucharczuk Colleen, Gorman Theresa, Bink Kristen, Moore Amy, Fitzpatrick Rebecca, Stadtmauer Edward A, Mangan Patricia, Kraus Kelly, Han Jennifer H: Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 25 (5): 1004-1010,2019.

Shah Jatin, Usmani Saad, Stadtmauer Edward A, Rifkin Robert M, Berenson James R, Berdeja Jesus G, Lyons Roger M, Klippel Zandra, Chang Yu-Lin, Niesvizky Ruben: Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma. Clinical lymphoma, myeloma & leukemia : 2019.

Lazarow Heather, Nicolo Michele, Compher Charlene, Kucharczuk Colleen R, Stadtmauer Edward A, Landsburg Daniel J: Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients. Clinical lymphoma, myeloma & leukemia 19 (7): e393-e398,2019.

Cohen Adam D, Garfall Alfred L, Stadtmauer Edward A, Melenhorst J Joseph, Lacey Simon F, Lancaster Eric, Vogl Dan T, Weiss Brendan M, Dengel Karen, Nelson Annemarie, Plesa Gabriela, Chen Fang, Davis Megan M, Hwang Wei-Ting, Young Regina M, Brogdon Jennifer L, Isaacs Randi, Pruteanu-Malinici Iulian, Siegel Don L, Levine Bruce L, June Carl H, Milone Michael C: B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. The Journal of clinical investigation 130 : 2210-2221,2019.

Stadtmauer Edward A, Pasquini Marcelo C, Blackwell Beth, Hari Parameswaran, Bashey Asad, Devine Steven, Efebera Yvonne, Ganguly Siddharta, Gasparetto Cristina, Geller Nancy, Horowitz Mary M, Koreth John, Knust Kristin, Landau Heather, Brunstein Claudio, McCarthy Philip, Nelson Courtney, Qazilbash Muzaffar H, Shah Nina, Vesole David H, Vij Ravi, Vogl Dan T, Giralt Sergio, Somlo George, Krishnan Amrita: Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 37 (7): 589-597,2019.

Bastidas Adriana, de la Serna Javier, El Idrissi Mohamed, Oostvogels Lidia, Quittet Philippe, López-Jiménez Javier, Vural Filiz, Pohlreich David, Zuckerman Tsila, Issa Nicolas C, Gaidano Gianluca, Lee Je-Jung, Abhyankar Sunil, Solano Carlos, Perez de Oteyza Jaime, Satlin Michael J, Schwartz Stefan, Campins Magda, Rocci Alberto, Vallejo Llamas Carlos, Lee Dong-Gun, Tan Sen Mui, Johnston Anna M, Grigg Andrew, Boeckh Michael J, Campora Laura, Lopez-Fauqued Marta, Heineman Thomas C, Stadtmauer Edward A, Sullivan Keith M: Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. JAMA 322 (2): 123-133,2019.

Garfall A, Dancy E, Cohen A, Wang WH, Frai J, Suhoski M, Levine B, Siegel D, Stadtmauer E, Vogl D, Waxman A, Rapoport A, Milone M, June C, Melenhorst J: T cell phenotypes associated with effective CAR T cell therapy in post-induction versus relapsed multiple myeloma Blood Advances : 2019.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-171
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 662-7910
Patient appointments: 800-789-7366 (PENN)

Related Links